Literature DB >> 3237993

The production of C3, PGE2 and TxB2 by splenic, alveolar, and peritoneal guinea pig macrophages.

C K Ogle1, J D Ogle, C Johnson, L Keynton, J W Alexander.   

Abstract

The synthesis and release of C3, PGE2, and TxB2 by cultured splenic, alveolar and peritoneal guinea pig macrophages in 24 hour culture was determined. There were significant differences in C3 production among all three sources of macrophages. Splenic macrophages produced significantly less PGE2 than alveolar or peritoneal macrophages. Peritoneal macrophages produced significantly more TxB2 than splenic or alveolar macrophages. The cells from the different sources appear to be different populations of macrophages.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3237993     DOI: 10.1016/0090-6980(88)90070-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  5 in total

1.  The role of the spleen, especially regarding changes in both thromboxane A2 and the remnant liver dysfunction after extensive hepatectomy.

Authors:  M Kitagawa; K Tanigawa; M Iwata
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Mononuclear phagocytes and eicosanoids: aspects of their synthesis and biological activities.

Authors:  U F Schade; I Burmeister; E Elekes; R Engel; D T Wolter
Journal:  Blut       Date:  1989-12

3.  Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6.

Authors:  C K Ogle; J Z Wu; X Mao; K Szczur; J W Alexander; J D Ogle
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

Review 4.  Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs.

Authors:  Alexandra Medeiros; Camila Peres-Buzalaf; Felipe Fortino Verdan; C Henrique Serezani
Journal:  Mediators Inflamm       Date:  2012-09-13       Impact factor: 4.711

Review 5.  Clinical experimentation with aerosol antibiotics: current and future methods of administration.

Authors:  Paul Zarogoulidis; Ioannis Kioumis; Konstantinos Porpodis; Dionysios Spyratos; Kosmas Tsakiridis; Haidong Huang; Qiang Li; J Francis Turner; Robert Browning; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2013-10-02       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.